LumaCyte provides researchers with a diagnostic tool that accelerates medical discoveries through a novel approach to cell analysis.
LumaCyte's investors include Malvern Panalytical.
LumaCyte is headquartered in Keswick, United States.
LumaCyte provides researchers with a diagnostic tool that accelerates medical discoveries through a novel approach to cell analysis.
LumaCyte is at the Series B stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"LumaCyte — Funding & Investors." VCBacked, September 6, 2023, https://www.vcbacked.co/company/lumacyte. Accessed August 14, 2026.
VCBacked. (2023). LumaCyte — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/lumacyte
{{cite web |title=LumaCyte — Funding & Investors |url=https://www.vcbacked.co/company/lumacyte |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated